Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - SOLIGENIX, INC.Financial_Report.xls
S-1 - REGISTRATION STATEMENT - SOLIGENIX, INC.fs12014_soligenix.htm
EX-23.1 - CONSENT OF EISNERAMPER LLP. - SOLIGENIX, INC.fs12014ex23i_soligenix.htm

EXHIBIT 21.1

 

SUBSIDIARIES OF SOLIGENIX, INC.

 

The following represents a list of Soligenix, Inc.’s subsidiaries:

 

Name  Ownership   State of Incorporation 
Enteron Pharmaceuticals, Inc.   100.00%   Delaware 
Orasomal Technologies Inc.   75.30%   Delaware 
DOR BioDefense Corp.   100.00%   Delaware 
Soligenix BioPharma Canada Incorporated   100.00%   Canada 
Soligenix UK Limited   100.00%   United Kingdom